Sivik Global Healthcare LLC Sells 10,000 Shares of Smith & Nephew plc (NYSE:SNN)

Sivik Global Healthcare LLC cut its holdings in Smith & Nephew plc (NYSE:SNN) by 6.7% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 140,000 shares of the medical equipment provider’s stock after selling 10,000 shares during the quarter. Smith & Nephew comprises 1.8% of Sivik Global Healthcare LLC’s portfolio, making the stock its 26th largest position. Sivik Global Healthcare LLC’s holdings in Smith & Nephew were worth $4,360,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the stock. Mather Group LLC. increased its holdings in Smith & Nephew by 9,735.3% in the second quarter. Mather Group LLC. now owns 1,672 shares of the medical equipment provider’s stock valued at $42,000 after purchasing an additional 1,655 shares during the period. Allspring Global Investments Holdings LLC grew its position in Smith & Nephew by 1,894.3% during the second quarter. Allspring Global Investments Holdings LLC now owns 1,735 shares of the medical equipment provider’s stock valued at $43,000 after buying an additional 1,648 shares during the period. EverSource Wealth Advisors LLC increased its holdings in Smith & Nephew by 92.5% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,454 shares of the medical equipment provider’s stock worth $61,000 after acquiring an additional 1,179 shares during the last quarter. GAMMA Investing LLC lifted its position in shares of Smith & Nephew by 160.0% during the third quarter. GAMMA Investing LLC now owns 2,257 shares of the medical equipment provider’s stock worth $70,000 after acquiring an additional 1,389 shares in the last quarter. Finally, Headlands Technologies LLC lifted its stake in Smith & Nephew by 225.0% in the 1st quarter. Headlands Technologies LLC now owns 3,851 shares of the medical equipment provider’s stock worth $98,000 after purchasing an additional 2,666 shares in the last quarter. 25.64% of the stock is owned by institutional investors and hedge funds.

Smith & Nephew Trading Up 0.4 %

NYSE SNN traded up $0.09 during trading on Thursday, hitting $24.71. The stock had a trading volume of 35,170 shares, compared to its average volume of 864,674. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 2.51. The stock has a market capitalization of $10.80 billion, a price-to-earnings ratio of 12.49, a P/E/G ratio of 1.28 and a beta of 0.85. The stock has a 50 day simple moving average of $29.00 and a 200 day simple moving average of $27.84. Smith & Nephew plc has a one year low of $23.65 and a one year high of $31.72.

Analysts Set New Price Targets

SNN has been the topic of several research reports. Deutsche Bank Aktiengesellschaft downgraded shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research note on Friday, November 1st. StockNews.com downgraded shares of Smith & Nephew from a “strong-buy” rating to a “buy” rating in a research report on Tuesday. Finally, Berenberg Bank lowered Smith & Nephew from a “buy” rating to a “hold” rating in a research report on Wednesday, November 6th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, Smith & Nephew presently has an average rating of “Hold”.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.